Newport, a Cortellis solution

Your single source of intelligence to grow your generics or API business

Strategically develop your generics portfolio, find API suppliers, gain insight as to when drugs can become generic, penetrate new markets, identify partners, and monitor your competition with Newport, a Cortellis solution.

Considerable time and expense are often spent gathering and analyzing all of the relevant data for confident, strategic decisions regarding your generics portfolio, best-fit API suppliers, and most feasible partners and markets to expand your business. Newport, a Cortellis solution integrates market, API, and patent data in a single, integrated location, providing a reliable, comprehensive resource for advanced product targeting, global API intelligence, and strategic business development:

  • A single source of all critical data for generics portfolio selection, API sourcing, and competitive intelligence
  • Comprehensive market data including sales, launch, consumption, and pack pricing
  • Validated API manufacturing intelligence with regulatory filing status, inspection dates, and more
  • Proprietary analytics, based on primary research, for deeper insight into when drugs can become generic, the competitiveness of the generic market for a given API, and capabilities of API manufacturers
  • Patent intelligence including tracking of paragraph IV patent challenges
15,500

Small molecules with synthesis schemes

1,400

Biologics with synthesis schemes

69,000

Manufacturers & marketers

33,000

Generics industry deals

>1,500,000

Patents in 92 countries and 6 PTOs

Unlock the hidden insights in data

Trusted by 85% of the world’s top 20 generic and API manufacturers and 70% of the top 10 fastest growing generics companies, Newport allows you to gain a competitive edge and stay on top of which generics and APIs are most likely to succeed.?

  • Quickly and accurately identify a short list of potential portfolio candidates with just a few clicks.?
  • Select a reliable, experienced API supplier that will be a good fit for your product using a source of expertly researched, validated data about API suppliers.
  • Conduct due diligence around the relevancy and feasibility of potential partners and new markets for portfolio expansion based on information about internal capabilities of the companies and the competitiveness of their product in your target markets.
Broad, deep global industry data

Quickly and thoroughly research new product and company opportunities using a single source of data regarding patents, sales, pack price, consumption, Paragraph IV challenges, API, the market share, companies, and launches. Sales data has been sourced from 5 regions, and launch data is available for 77 countries.

Proven, time-saving analytics

Make faster, better decisions using proprietary analytics such as the Newport Constraint Date (covering 36 countries), API Availability Rating, and API Manufacturing Status.?

Powerful targeting features

Efficiently access and analyze data to quickly develop a short list of potential portfolio candidates or partners meeting your specific criteria for drug characteristics, partner experience and capabilities, and your strategy.

Unique intelligence

Have greater confidence in your decisions concerning your strategy using a solution that provides market, API, and patent intelligence in a single platform, helping determine the drug candidates with the greatest probability of success as well as API manufacturers best suited to your needs.

Latest information

Stay current with email alerts for new or updated product or company data.

Product log in

Log in to your existing Newport Premium account.

Log in

Speak to our team

Want to learn more about Newport Premium?

Contact Us
德州扑克王